Gastrointestinal Diseases Biochip
Why use Biochip?
In the UK, there are 1 million consultations per day in primary care. Gastrointestinal (GI) complaints account for up to 10% of these consultations. A further 50% of these consultations are for upper GI symptoms such as dyspepsia (epigastric pain/indigestion).
Results from a systematic review:
Around 80% of patients with dyspepsia had a normal endoscopy. These patients likely had functional dyspepsia (no pathology or obvious cause for symptoms).
*Used in conjunction with a Pepsinogen I/II Ratio Calculation
Biochip Markers
| Gastrin-17 | Pepsinogen I |
| Pepsinogen II | - |
Application
Aiding clinicians with fast-track stratification to identify the following:
Significantly reducing and eliminating the need for:
The Evidence MultiSTAT
Meet the Evidence MultiSTAT
The Evidence MultiSTAT is an easy to use, small footprint analyser facilitating on-site simultaneous detection of multiple biomarkers.
Using chemiluminescence as a measurement principle, the Evidence MultiSTAT consistently delivers accurate results.
With minimal sample preparation required, this versatile benchtop analyser can achieve accurate, quantitative results in minutes.
Meet the Cartridge
The Evidence MultiSTAT cartridge contains the reagents required for the chemiluminescent reaction to take place incorporated into its wells.
The process from sample entry to results can be completed in 2 simple steps, with minimal risk of human error.
No other components are required.
